Published in Health Phys on June 01, 1972
Quantitative plutonium microdistribution in bone tissue of vertebra from a Mayak worker. Health Phys (2010) 0.75
A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med (2001) 9.98
Antibiotic susceptibility patterns as aids in classification and characterization of gram-negative anaerobic bacilli. J Bacteriol (1967) 5.67
Lincomycin: activity against anaerobes and effect on normal human fecal flora. Antimicrob Agents Chemother (Bethesda) (1965) 3.29
Metabolism of reduced methylated sulfur compounds in anaerobic sediments and by a pure culture of an estuarine methanogen. Appl Environ Microbiol (1986) 3.25
Selenate reduction to elemental selenium by anaerobic bacteria in sediments and culture: biogeochemical significance of a novel, sulfate-independent respiration. Appl Environ Microbiol (1989) 2.74
Antidepressants and cancer: cause for concern? J Clin Psychopharmacol (1993) 2.43
Antibacterial sensitivity of Bifidobacterium (Lactobacillus bifidus). J Bacteriol (1967) 2.21
Isolation, Growth, and Metabolism of an Obligately Anaerobic, Selenate-Respiring Bacterium, Strain SES-3. Appl Environ Microbiol (1994) 2.13
Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clin Microbiol Infect (2009) 2.04
Arsenic(III) fuels anoxygenic photosynthesis in hot spring biofilms from Mono Lake, California. Science (2008) 1.98
Reversible alterations in immunoregulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry. Chest (1982) 1.76
Pulsed-field gel electrophoresis and ribotype profiles of clinical and environmental Vibrio vulnificus isolates. Appl Environ Microbiol (1996) 1.72
Ataxia and slurred speech after artesunate treatment for falciparum malaria. N Engl J Med (1997) 1.72
Estrogen and bone-muscle strength and mass relationships. Bone (1998) 1.72
On the rat model of human osteopenias and osteoporoses. Bone Miner (1992) 1.58
White paper on herbal products. American College of Clinical Pharmacy. Pharmacotherapy (2000) 1.58
Three-pool model of the long-term turnover of plasma cholesterol in man. J Lipid Res (1973) 1.58
Degradation of methyl bromide by methanotrophic bacteria in cell suspensions and soils. Appl Environ Microbiol (1994) 1.54
Bacterial oxidation of methyl bromide in fumigated agricultural soils. Appl Environ Microbiol (1997) 1.53
Dissimilatory arsenate and sulfate reduction in sediments of two hypersaline, arsenic-rich soda lakes: Mono and Searles Lakes, California. Appl Environ Microbiol (2006) 1.52
Patients with methicillin-resistant Staphylococcus aureus infection: twenty-first century lepers. J Hosp Infect (2010) 1.48
Tardive akathisia: an analysis of clinical features and response to open therapeutic trials. Mov Disord (1989) 1.44
Reducing total dietary fat without reducing saturated fatty acids does not significantly lower total plasma cholesterol concentrations in normal males. Am J Clin Nutr (1992) 1.42
Possible interaction between fluoxetine and pimozide causing sinus bradycardia. Can J Psychiatry (1993) 1.41
Toward a greater understanding of the parents of the mentally retarded child. J Pediatr (1968) 1.39
What is the relevance of antiretroviral therapy that does not include protease inhibitors? Clin Infect Dis (1998) 1.39
Estimating the cost of nosocomial candidemia in the united states. Clin Infect Dis (2001) 1.38
The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Clin Microbiol Infect (2012) 1.34
Metabolic acidosis resulting from intravenous alimentation mixtures containing synthetic amino acids. N Engl J Med (1972) 1.29
Excessive mineralization with growth plate closure in rats on chronic warfarin treatment. Proc Natl Acad Sci U S A (1982) 1.24
In situ bacterial selenate reduction in the agricultural drainage systems of western Nevada. Appl Environ Microbiol (1991) 1.23
Staphylococcus aureus is the most common identified cause of cellulitis: a systematic review. Epidemiol Infect (2009) 1.19
T-lymphocyte subsets in smoking and lung cancer: Analysis of monoclonal antibodies and flow cytometry. Am Rev Respir Dis (1982) 1.17
Observations on the distribution and ecology of Clostridium botulinum type E in Alaska. Can J Microbiol (1975) 1.16
Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis. Clin Infect Dis (2001) 1.13
Ethane-1-hydroxy-1, 1-diphosphonate (EHDP). Effects on growth and modeling of the rat tibia. Calcif Tissue Res (1975) 1.11
Perspectives: some roles of mechanical usage, muscle strength, and the mechanostat in skeletal physiology, disease, and research. Calcif Tissue Int (1998) 1.10
Advice of manufacturers about effects of temperature on biologicals. Am J Hosp Pharm (1985) 1.09
A weighted least-squares technique for the analysis of kinetic data and its application to the study of renal xenon washout in dogs and man. Circ Res (1973) 1.09
Available animal models of osteopenia--small and large. Bone (1995) 1.08
1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis. Proc Natl Acad Sci U S A (1982) 1.07
Prediction of the parameters of whole body cholesterol metabolism in humans. J Lipid Res (1980) 1.06
Growth, nutrient retention, and metabolic response of low-birth-weight infants fed supplemented and unsupplemented preterm human milk. Am J Clin Nutr (1990) 1.06
The effects of prostaglandin E2 in growing rats: increased metaphyseal hard tissue and cortico-endosteal bone formation. Calcif Tissue Int (1985) 1.06
Quantitative displacement of acid-base equilibrium in metabolic acidosis. Ann Intern Med (1967) 1.06
Effects of spaceflight on trabecular bone in rats. Am J Physiol (1983) 1.05
Reduction of plasma cholesterol levels in normal men on an American Heart Association Step 1 diet or a Step 1 diet with added monounsaturated fat. N Engl J Med (1990) 1.05
The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat. Anat Rec (1979) 1.04
Humoral and ionic regulation of osteoclast acidity. Calcif Tissue Int (1986) 1.03
Human adipocyte cholesterol. Concentration, localization, synthesis, and turnover. J Clin Invest (1975) 1.03
The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. Transplantation (1994) 1.03
The progress of the periodontal syndrome in the rice cat. II. The effects of a diphosphonate on the periodontium. J Periodontal Res (1981) 1.01
Effects of CP-336,156, a new, nonsteroidal estrogen agonist/antagonist, on bone, serum cholesterol, uterus and body composition in rat models. Endocrinology (1998) 1.01
Growth, nutrient retention, and metabolic response in low birth weight infants fed varying intakes of protein and energy. J Pediatr (1988) 1.00
Time responses of cancellous and cortical bones to sciatic neurectomy in growing female rats. Bone (1996) 1.00
Radioautographic studies of inulin, sulfate and chloride in rat and guinea pig thyroid glands. Endocrinology (1965) 0.99
Studies on the role of vitamin D in early skeletal development, mineralization, and growth in rats. Calcif Tissue Int (1983) 0.98
Anaerobic bacteria as cause of the blind loop syndrome. A case report with observations on response to antibacterial agents. Gastroenterology (1968) 0.98
Sustained release of acetaminophen from heterogeneous matrix tablets: influence of polymer ratio, polymer loading, and co-active on drug release. Pharm Dev Technol (1997) 0.96
Measurement of regional myocardial perfusion in man with 133 xenon and a scintillation camera. J Clin Invest (1972) 0.96
A quantitative histologic analysis of the growing long bone metaphysis. Calcif Tissue Int (1980) 0.96
T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia. Endocrinology (1996) 0.96
Parameters of the three-pool model of the turnover of plasma cholesterol in normal and hyperlipidemic humans. J Clin Invest (1976) 0.95
Bone lining cells: structure and function. Scanning Microsc (1989) 0.95
Non-suppurative cellulitis: risk factors and its association with Staphylococcus aureus colonization in an area of endemic community-associated methicillin-resistant S. aureus infections. Epidemiol Infect (2010) 0.94
Possible origin of Clostridium botulinum contamination of Eskimo foods in northwestern Alaska. Appl Microbiol (1972) 0.94
Turnover of the plasma binding protein for vitamin D and its metabolites in normal human subjects. J Clin Endocrinol Metab (1981) 0.93
Experimental Brucella suis type 4 infections in domestic and wild Alaskan carnivores. J Wildl Dis (1981) 0.93
Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia. Endocrinology (1994) 0.93
Asbestos exposure correlates with alterations in circulating T cell subsets. Clin Exp Immunol (1983) 0.93
Variations in mineral apposition rate of trabecular bone within the beagle skeleton. Calcif Tissue Int (1981) 0.92
Oxygen method for calculation of right to left shunt: new application in presence of right to left shunting through the ductus arteriosus. Cardiovasc Res (1972) 0.92
Cholesterol turnover in lipid phases of human atherosclerotic plaque. J Lipid Res (1982) 0.92
Parathyroid hormone and mechanical usage have a synergistic effect in rat tibial diaphyseal cortical bone. J Bone Miner Res (1999) 0.92
Benzodiazepine receptor binding of nonbenzodiazepines in vivo: alpidem, zolpidem and zopiclone. Brain Res Bull (1992) 0.92
Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons. Transpl Infect Dis (2012) 0.91
Degradation of methyl bromide in anaerobic sediments. Environ Sci Technol (1994) 0.91
A quantitative histologic study of bone turnover in young adult beagles. Anat Rec (1982) 0.91
The role of prostaglandins in bone in vivo. Prostaglandins Leukot Essent Fatty Acids (1990) 0.90
Further studies on tularemia in Alaska: virulence and biochemical characteristics of indigenous strains. Can J Microbiol (1974) 0.90
Evidence for reduced cancellous bone mass in the spontaneously hypertensive rat. Bone Miner (1993) 0.90
Adaptation of cancellous bone to aging and immobilization in the rat: a single photon absorptiometry and histomorphometry study. Anat Rec (1990) 0.90
Methylmercury oxidative degradation potentials in contaminated and pristine sediments of the carson river, nevada. Appl Environ Microbiol (1995) 0.89
The progress of the periodontal syndrome in the rice rat. I. Morphometric and autoradiographic studies. J Periodontal Res (1981) 0.89
Lack of relationship in humans of the parameters of body cholesterol metabolism with plasma levels of subfractions of HDL or LDL, or with apoE isoform phenotype. J Lipid Res (1986) 0.89
Effects of varying protein and energy intakes on growth and metabolic response in low birth weight infants. J Pediatr (1986) 0.89
Ethane-1-hydroxy-1, 1-diphosphonate (EHDP) effects on incorporation and accumulation of osteoclast nuclei. Calcif Tissue Res (1977) 0.89
Relationship of the parameters of body cholesterol metabolism with plasma levels of HDL cholesterol and the major HDL apoproteins. J Lipid Res (1985) 0.89
Predictors of bone mass by peripheral quantitative computed tomography in early adolescent girls. J Clin Densitom (2001) 0.89
Chronic cocaine administration is associated with behavioral sensitization and time-dependent changes in striatal dopamine transporter binding. J Pharmacol Exp Ther (1994) 0.88
The bone lining cell: a distinct phenotype? Calcif Tissue Int (1987) 0.88
The relationship of bone strength and bone quantity in health, disease, and aging. J Gerontol (1966) 0.88
Further studies on tularemia in Alaska: human tularemia. Can J Microbiol (1974) 0.88
Rapamycin: a bone sparing immunosuppressant? J Bone Miner Res (1995) 0.88
Bone cell kinetics during longitudinal bone growth in the rat. Calcif Tissue Int (1980) 0.88
Decreased GABAA receptor subunit mRNA concentrations following chronic lorazepam administration. Br J Pharmacol (1991) 0.88